DARE
Price:
$2.02
Market Cap:
$19.23M
Daré Bioscience, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering, developing, and bringing to market healthcare solutions specifically for women in the United States. Its comprehensive pipeline addresses a broad spectrum of needs within women's health, encompassing contraception, fertility, and both sexual and vaginal well-being. The company's initial commercial offering is XACIATO, a prescription single-dose vaginal gel designed to treat bacterial vaginosis in female patients from 12 years of age. Daré has established a licensing agreement with Organon & Co. and Organon International GmbH to commercialize this product. Beyond its marketed therapy, Daré boas...[Read more]
Industry
Biotechnology
IPO Date
2014-04-10
Stock Exchange
NASDAQ
Ticker
DARE
According to Daré Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.90M. This represents a change of -32.60% compared to the average of 11.72M of the last 4 quarters.
The mean historical Enterprise Value of Daré Bioscience, Inc. over the last ten years is 59.12M. The current 7.90M Enterprise Value has changed 1.24% with respect to the historical average. Over the past ten years (40 quarters), DARE's Enterprise Value was at its highest in in the September 2016 quarter at 3.44T. The Enterprise Value was at its lowest in in the March 2018 quarter at -8351720.40.
Average
59.12M
Median
27.84M
Minimum
-564670.68
Maximum
213.35M
Discovering the peaks and valleys of Daré Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.50%
Maximum Annual Enterprise Value = 213.35M
Minimum Annual Increase = -245.76%
Minimum Annual Enterprise Value = -564670.68
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 193.69M | 1.50% |
| 2024 | 12.12M | -38.39% |
| 2023 | 19.66M | -45.40% |
| 2022 | 36.02M | -49.20% |
| 2021 | 70.90M | 94.70% |
| 2020 | 36.42M | 314.16% |
| 2019 | 8.79M | 968.29% |
| 2018 | 823.06K | -245.76% |
| 2017 | -564670.68 | -100.26% |
| 2016 | 213.35M | -73.29% |
The current Enterprise Value of Daré Bioscience, Inc. (DARE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
75.16M
5-year avg
66.48M
10-year avg
59.12M
Daré Bioscience, Inc.’s Enterprise Value is greater than FibroBiologics, Inc. Common Stock (2.70M), greater than Citius Pharmaceuticals, Inc. (2.25M), less than Leap Therapeutics, Inc. (30.18M), less than Ainos, Inc. (16.81M), greater than Athira Pharma, Inc. (1.07M), greater than Aspire Biopharma Holdings, Inc. (-4785565.00), greater than Aditxt, Inc. (3.97M), less than Palisade Bio, Inc. (164.19M), less than Adlai Nortye Ltd. (550.38M), less than Hoth Therapeutics, Inc. (20.84M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.70M | $1.95M | |
| 2.25M | $6.03M | |
| 30.18M | $31.86M | |
| 16.81M | $8.65M | |
| 1.07M | $26.62M | |
| -4785565.00 | $572.25K | |
| 3.97M | $425.00 | |
| 164.19M | $296.82M | |
| 550.38M | $547.79M | |
| 20.84M | $14.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Daré Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Daré Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Daré Bioscience, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Daré Bioscience, Inc. (DARE)?
What is the 3-year average Enterprise Value for Daré Bioscience, Inc. (DARE)?
What is the 5-year average Enterprise Value for Daré Bioscience, Inc. (DARE)?
How does the current Enterprise Value for Daré Bioscience, Inc. (DARE) compare to its historical average?